BioNTech


Couple who stopped COVID-19 promise cancer vaccine by 2030

These two doctors developed one of the vaccines against COVID-19. It's believed that they will succeed in developing a vaccine against specific cancers in the next eight years.

Founders of BioNTech, Dr. Ugur Sahin and Dr. Ozlem Tureci
 Coronavirus cells (illustrative)

COVID: Omicron BA.2 infection after vaccine can protect from BA.4/BA.5 - study

 Vials of the Pfizer-BioNTech Comirnaty coronavirus disease (COVID-19) vaccine are pictured in a General practitioners practice in Berlin, Germany, April 10, 2021.

EU regulator backs two Omicron-adapted COVID boosters

Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.

Moderna sues Pfizer and BioNTech over COVID-19 vaccine


COVID-19 booster shot significantly boosts efficacy - study

The estimated vaccine effectiveness of the third dose against PCR-confirmed infection stood at 85.6% compared to the two doses, Sheba researchers found.

Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.

FDA green lights second COVID-19 booster shot for older Americans

Pfizer and BioNTech originally asked for the next booster doses to be authorized for people 65 and older in a submission citing data collected in Israel.

 Health care worker takes swab samples from Israelis at a covid-19 drive through testing complex in Modi'in, February 1, 2022.

Pfizer vaccine for children under 5 may be available in US by end-Feb - report

The report says that the FDA urged the companies to submit the application so that regulators could begin reviewing the two-shot data.

Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.

US FDA authorizes Pfizer/BioNTech booster for 16- and 17-year-olds

All US adults are currently eligible for booster shots of the three authorized COVID-19 vaccines.

Signage is seen outside of FDA headquarters in White Oak, Maryland.

US FDA evaluating effectiveness of COVID-19 vaccines against Omicron

BioNTech and Pfizer's established COVID-19 vaccine will likely offer strong protection against any severe disease from the new Omicron virus variant.

Signage is seen outside of FDA headquarters in White Oak, Maryland.

Number of families affected by Alzheimer's may triple by 2050 - pharma company

AC Immune's CEO Andrea Pfeifer described Alzheimer's as 'a slow pandemic rolling towards the world.'

 Patients with Alzheimer's and dementia are sit inside the Alzheimer foundation in Mexico City

Combining AstraZeneca, mRNA COVID-19 vaccines 88% effective - Danish study

"The study shows that fourteen days after a combined vaccination program, the risk of infection with SARS-CoV-2 is reduced by 88% compared to unvaccinated individuals," the State Serum Institute said

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021

Pfizer seeks authorization for COVID booster shot from US, Europe

The US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) said that Americans who have been fully vaccinated do not need a booster COVID-19 shot at this time.

Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.

US children ages 12 to 15 could begin COVID-19 vaccinations Thursday

The vaccine has been available under an emergency use authorization to people as young as 16 in the United States.

An illustrative photo of the Pfizer COVID-19 vaccine.